000 | 02217cgm a2200445 a 4500 | ||
---|---|---|---|
001 | HST1593_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 180914s2018 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a1593 _bHenry Stewart Talks |
035 | _a(UkLoHST)515 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aVolberding, Paul. _4spk |
|
245 | 1 | 0 |
_aHIV therapy _h[electronic resource] : _btaking advantage of progress / _cPaul Volberding. |
260 |
_aLondon : _bHenry Stewart Talks, _c2018. |
||
300 |
_a1 online resource (1 streaming video file (34 min.) : _bcolor, sound). |
||
490 | 1 |
_aRetroviruses : biology, pathogenic mechanisms and treatment, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
500 | _aUpdated version of a talk first published in 2007 under the title: Opening the pathway to current, effective antiretroviral therapy. | ||
505 | 0 | _aContents: Goals and benefits of antiretroviral therapy -- When to begin antiretroviral treatment -- First line and HIV treatment model -- Avoiding side effects and drug resistance -- New approaches in progress -- Role of antiretroviral drugs in prevention of infection -- Curing HIV infection -- HIV care systems. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aAIDS (Disease) _xPrevention. |
|
650 | 0 | _aAntiretroviral agents. | |
650 | 0 |
_aHIV infections _xTreatment. |
|
650 | 2 |
_aAcquired Immunodeficiency Syndrome _xprevention & control. |
|
650 | 2 |
_aAnti-HIV Agents _xadverse effects. |
|
650 | 2 |
_aAnti-HIV Agents _xtherapeutic use. |
|
650 | 2 |
_aAnti-Retroviral Agents _xtherapeutic use. |
|
650 | 2 | _aDrug Resistance. | |
650 | 2 |
_aHIV Infections _xdrug therapy. |
|
650 | 2 |
_aHIV Infections _xprevention & control. |
|
740 | 0 | _aOpening the pathway to current, effective antiretroviral therapy. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pRetroviruses : biology, pathogenic mechanisms and treatment. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/515/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/36/ _3Series |
999 |
_c76307 _d76307 |